These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4075906)

  • 1. [Therapeutic effect of budipin in treating Parkinson's disease].
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):197-8. PubMed ID: 4075906
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parkinson diseases--polyvalent therapy with Budipin].
    Nervenarzt; 1998 Feb; 69(2 Suppl Morbus Par):1-8. PubMed ID: 9532230
    [No Abstract]   [Full Text] [Related]  

  • 3. Preclamol. A "designer drug" in the treatment of advanced Parkinson's disease.
    Pirtosek Z; Merello M; Carlsson A; Stern G
    Adv Neurol; 1996; 69():535-40. PubMed ID: 8615177
    [No Abstract]   [Full Text] [Related]  

  • 4. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
    Kline NS; Mason BT; Winick L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of ciladopa on Parkinson's disease: a preliminary report.
    Weiner WJ; Berger JR
    Adv Neurol; 1987; 45():583-6. PubMed ID: 3548268
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nursing process: nursing of patients with Parkinson's disease. Nursing before and after withdrawal for the purpose of medication control of patients with Parkinson's disease].
    Kanagawa M; Osaga W; Ishii T; Saika M; Ishii T
    Kurinikaru Sutadi; 1985 Aug; 6(8):933-9. PubMed ID: 3850295
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison between the effects of L-dopa, prodipine and amantadine on the serum and CSF amino acid levels in Parkinson's disease (author's transl)].
    Gründig E; Gerstenbrand F
    Wien Klin Wochenschr; 1980 Dec; 92(24):868-71. PubMed ID: 7222702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of methamidoline in the treatment of parkinson-like manifestations due to neuroleptics].
    Arnone A; Parodi A
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1126-42. PubMed ID: 5143724
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined treatment in Parkinson's disease.
    Wheatley D
    Practitioner; 1983 Mar; 227(1377):446-7. PubMed ID: 6889232
    [No Abstract]   [Full Text] [Related]  

  • 10. Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings.
    Spieker S; Löschmann P; Jentgens C; Boose A; Klockgether T; Dichgans J
    Clin Neuropharmacol; 1995 Jun; 18(3):266-72. PubMed ID: 8635185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic indications in Parkinson's disease].
    Petit H
    LARC Med; 1983; 3(6):433-5. PubMed ID: 6888113
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary clinical trial of tetrahydropapaveroline in Parkinson's disease].
    Dordain G; Goujet MA; Simon P
    Therapie; 1974; 29(3):421-34. PubMed ID: 4612860
    [No Abstract]   [Full Text] [Related]  

  • 13. Preclamol and parkinsonian fluctuations.
    Pirtosek Z; Merello M; Carlsson A; Stern G
    Clin Neuropharmacol; 1993 Dec; 16(6):550-4. PubMed ID: 9377590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategies recommended for early stage Parkinson's disease].
    Derkinderen P
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():82-90. PubMed ID: 10916041
    [No Abstract]   [Full Text] [Related]  

  • 15. Case studies in the advancement of Parkinson's disease.
    Frei K; Truong DD; Wolters E
    CNS Spectr; 2008 Dec; 13(12 Suppl 18):1-6. PubMed ID: 19179948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment challenges in early stage Parkinson's disease.
    Tetrud J
    Neurol Clin; 2004 Oct; 22(3 Suppl):S19-33. PubMed ID: 15501364
    [No Abstract]   [Full Text] [Related]  

  • 17. Motor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in Parkinson's disease.
    Metman LV; Sethy VH; Roberts JR; Bravi D; Hoff JI; Mouradian MM; Chase TN
    Mov Disord; 1994 Sep; 9(5):577-81. PubMed ID: 7990854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease.
    Clarke CE; Moore AP
    Am Fam Physician; 2007 Apr; 75(7):1045-8. PubMed ID: 17427619
    [No Abstract]   [Full Text] [Related]  

  • 19. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing early Parkinson's disease.
    Clarke CE
    Practitioner; 1999 Jan; 243(1594):39, 42-5, 47. PubMed ID: 10436571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.